Penn Medicine takes a multidisciplinary approach to evaluate and treat patients diagnosed with gastrointestinal (GI) and liver cancers. Our GI specialists work in collaboration with Penn’s Abramson Cancer Center to provide a well-rounded, comprehensive plan of action. Our physicians are leaders in treating patients with combined therapies which may include endoscopic procedures, surgery, chemotherapy and radiation.
Gastrointestinal (GI) Cancer Program
For patients who have been diagnosed with gastrointestinal cancer, Penn offers a program to help you through treatment and after care. You'll receive attention from a multi-specialty team that follows your case from start to finish, no matter what type of GI cancer you are facing. Read more about our GI Cancer Program.
GI Cancer Genetic Screening
You may be at risk for gastrointestinal cancer if you have a personal or family history of colon polyps, colon cancer or other gastrointestinal cancers (pancreatic, stomach, esophageal or liver). If you are concerned about the risk of GI cancer, you may want to consider genetic screening. Our GI Cancer Genetics Program at Penn's Abramson Cancer Center offers patients who are at an increased risk of developing gastrointestinal cancer access to advanced genetic testing, information, evaluation and clinical services. Our team of GI cancer experts work together across multiple specialties and offer support to patients through each step of the risk evaluation program.
GI Cancer Risk Evaluation
Penn Medicine is at the forefront of cancer risk evaluation, offering latest advancements in colorectal cancer screening and GI cancer risk evaluation. The GI Cancer Risk Evaluation Program offers information, evaluation, and follow-up for people who are at increased risk of developing a gastrointestinal cancer.
In This Section
Penn Medicine offers advanced approaches for the treatment of GI and liver cancers.